Literature DB >> 11082389

Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?

B Pouzet1, J T Vilquin, A A Hagège, M Scorsin, E Messas, M Fiszman, K Schwartz, P Menasché.   

Abstract

BACKGROUND: Autologous skeletal myoblast (SM) transplantation improves function of infarcted myocardium, but pretransplantation cultures remain a complex process. This study assessed whether it could be optimized by muscle preconditioning with the local anesthetic bupivacaine or even bypassed with the use of the so-called mince technique. METHODS AND
RESULTS: Muscle preconditioning consisted of intramuscular injections of the tibialis anterior of rats, 2 days before harvest. After 7 days of culture, the number of available myoblasts was significantly increased compared with nonconditioned controls (1 683 147 versus 85 300, P:=0.0013). The mince technique was then assessed. A myocardial infarction was created in 66 rats by coronary artery ligation. One week later, rats were reoperated on and intramyocardially injected with culture medium alone (controls, n=23), autologous cultured SM (3.5 x 10(6), n=21), or autologous muscle minced into a fine slurry, which was immediately transplanted (n=22). All muscles had been preconditioned. Left ventricular function was assessed by 2D echocardiography. Whereas end-diastolic volumes expanded over time in all groups, left ventricular ejection fraction (%, mean+/-SEM) was increased only in the cultured SM-transplanted group at 1 (P:=0. 0006) and 2 months (P:=0.0008) versus baseline (37.52+/-1.92 and 40. 92+/-2.17 versus 30.34+/-1.74), with a significant additional benefit between 1 and 2 months (P:=0.0069).
CONCLUSIONS: Cell culture remains mandatory for SM transplantation to be successful but, in a clinical perspective, this process can be made more expeditious by preharvest muscle conditioning with bupivacaine, which greatly enhances the baseline cell yield.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082389     DOI: 10.1161/01.cir.102.suppl_3.iii-210

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Cardiac resynchronization by cardiosphere-derived stem cell transplantation in an experimental model of myocardial infarction.

Authors:  Michael Bonios; Connie Y Chang; Aurelio Pinheiro; Veronica Lea Dimaano; Takahiro Higuchi; Christina Melexopoulou; Frank Bengel; John Terrovitis; Theodore P Abraham; M Roselle Abraham
Journal:  J Am Soc Echocardiogr       Date:  2011-04-20       Impact factor: 5.251

2.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host.

Authors:  Bertrand Leobon; Isabelle Garcin; Philippe Menasche; Jean-Thomas Vilquin; Etienne Audinat; Serge Charpak
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-12       Impact factor: 11.205

Review 3.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 4.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 5.  Skeletal myoblasts for cardiac repair.

Authors:  Shazia Durrani; Mikhail Konoplyannikov; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

6.  MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases.

Authors:  Husnain Kh Haider; Ye Lei; Muhammad Ashraf
Journal:  Curr Opin Mol Ther       Date:  2008-12

7.  Preconditioning of Human Skeletal Myoblast with Stromal Cell-derived Factor-1α Promotes Cytoprotective Effects against Oxidative and Anoxic Stress.

Authors:  Ibrahim Elmadbouh; Husnain Kh Haider; Muhammad Ashraf; Juan-Carlos Chachques
Journal:  Int J Stem Cells       Date:  2011-06       Impact factor: 2.500

Review 8.  Reprogramming cells for transplantation.

Authors:  Jonathan Leor; Alexander Battler; Robert A Kloner; Sharon Etzion
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

9.  Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation.

Authors:  Seyedhossein Aharinejad; Dietmar Abraham; Patrick Paulus; Karin Zins; Michael Hofmann; Wolfgang Michlits; Mariann Gyöngyösi; Karin Macfelda; Trevor Lucas; Karola Trescher; Michael Grimm; E Richard Stanley
Journal:  Cardiovasc Res       Date:  2008-04-23       Impact factor: 10.787

10.  Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias.

Authors:  Sarah Fernandes; Harold V M van Rijen; Virginie Forest; Stéphane Evain; Anne-Laure Leblond; Jean Mérot; Flavien Charpentier; Jacques M T de Bakker; Patricia Lemarchand
Journal:  J Cell Mol Med       Date:  2009-03-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.